Acute kidney injury is a sudden decrease in kidney function that can lead to kidney failure, the need for kidney dialysis and death.

The Young Physician-Scientist Award recognizes “notable achievements” by researchers who are within five years of their first faculty appointment.

The report supports previous clinical trials that found the GLP-1 receptor agonist drug semaglutide reduced kidney disease progression in patients with Type 2 diabetes.

A kidney protein that responds to low levels of blood potassium — which can cause high blood pressure and cardiovascular problems — may be a target for new therapeutics.

A U.S.-Canadian research collaboration led by Vanderbilt University Medical Center has identified common, age-associated changes in the blood as a risk factor for acute kidney injury, which occurs in more than 1 in 5 hospitalized adults worldwide.

Vanderbilt's Yash Choksi, MD, recently received the 2024 Research Investigator Early Career Faculty Award from the Southern Society for Clinical Investigation and Fabian Bock, MD, PhD, won the society's Research Scholar Award.